−14.3
Inhibikase Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
−17.4
FY23:
−18.1
FY24:
−19.1
FY25:
−27.8
millions USD
FY21:
0
FY22:
−16.0
FY23:
11.7
FY24:
−37.0
FY25:
2.05
Change from FY21 to FY25
millions USD
FY21:
41.1
FY22:
−0.20
FY23:
8.41
FY24:
103
FY25:
108
(positive)
Change from FY21 to FY25
millions USD
FY21:
−14.3
FY22:
−17.6
FY23:
−18.1
FY24:
−19.1
FY25:
−27.8
All amounts in millions USD